Literature DB >> 17619552

The unusual suspects: a surprise regarding reactions to omalizumab.

Phil Lieberman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619552     DOI: 10.2500/108854107781285717

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  2 in total

Review 1.  [Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].

Authors:  B Sachs; H F Merk
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

2.  Omalizumab therapy in three patients with chronic autoimmune urticaria.

Authors:  Mona Al-Ahmad
Journal:  Ann Saudi Med       Date:  2010 Nov-Dec       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.